M&A Corner
ACELYRIN, INC. Furthers Leadership Position in Immunology with Transformative Acquisition of ValenzaBio09 Jan 2023
Adds clinical- and pre-clinical immunology assets to pipeline including a potentially differentiated therapeutic for the treatment of Thyroid Eye Disease... Continue Reading
|
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research09 Jan 2023
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine SANTA CLARA,... Continue Reading
|
Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics09 Jan 2023
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company’s confidence in, and commitment... Continue Reading
|
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company09 Jan 2023
Orthofix and SeaSpine Stockholders Approve Merger LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their... Continue Reading
|
Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit09 Jan 2023
SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / (OTC:PLPL) Plandai Biotechnology, Inc. (“Plandai” or the “Company”) announces the termination of its... Continue Reading
|
Moderna to Acquire OriCiro Genomics09 Jan 2023
OriCiro’s synthetic biology and enzyme technologies will support Moderna’s expanding portfolio of therapeutics and vaccines Acquisition will bolster Moderna’s suite... Continue Reading
|
Amazon’s One Medical acquisition passes regulatory hurdle in Oregon09 Jan 2023
Photo: Sundry Photography/Getty Images Amazon cleared a regulatory hurdle in Oregon as it advances its plans to acquire primary care... Continue Reading
|
Aurinia and Sun Pharma File Joint Motion to Settle Patent Dispute09 Jan 2023
Aurinia Pharmaceuticals has agreed to jointly file a motion with India’s Sun Pharmaceuticals (Sun Pharma) to dismiss the inter parties review of patent... Continue Reading
|
AmerisourceBergen Completes Acquisition of PharmaLex09 Jan 2023
Acquisition advances role as a partner of choice for biopharmaceutical companies by enhancing global portfolio of specialty services CONSHOHOCKEN, Pa.–(BUSINESS... Continue Reading
|
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy09 Jan 2023
JERSEY CITY, N.J.–(BUSINESS WIRE)– Organon (NYSE: OGN), a global women’s healthcare company, today announced a strategic investment in Claria Medical, Inc. a... Continue Reading
|